| Dir : /home/ithome/mail/new/ |
| Server: Linux host100322.itwesthosting.com 3.10.0-1160.144.1.el7.tuxcare.els4.x86_64 #1 SMP Tue Apr 7 08:40:40 UTC 2026 x86_64 IP: 144.91.64.173 |
| Dir : /home/ithome/mail/new/1773912078.M690973P4830.host100322.itwesthosting.com,S=26977,W=27352 |
Return-Path: <j.feedback@sjams.net>
Delivered-To: ithome@host100322.itwesthosting.com
Received: from host100322.itwesthosting.com
by host100322.itwesthosting.com with LMTP
id uMMPKQ7Au2neEgAAp0YrwQ
(envelope-from <j.feedback@sjams.net>)
for <ithome@host100322.itwesthosting.com>; Thu, 19 Mar 2026 10:21:18 +0100
Return-path: <j.feedback@sjams.net>
Envelope-to: ljerka.pavkovic@bolnica-lipik.hr
Delivery-date: Thu, 19 Mar 2026 10:21:18 +0100
Received: from static195-73.de.dm.aliyun.com ([47.245.195.73]:49910)
by host100322.itwesthosting.com with esmtps (TLS1.2) tls TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384
(Exim 4.96.2)
(envelope-from <j.feedback@sjams.net>)
id 1w39Z7-0001Iv-0S
for ljerka.pavkovic@bolnica-lipik.hr;
Thu, 19 Mar 2026 10:21:18 +0100
X-AliDM-RcptTo: bGplcmthLnBhdmtvdmljQGJvbG5pY2EtbGlwaWsuaHI=
Feedback-ID: default:j.feedback@sjams.net:vip_superior_SmtpBatch:48263
DKIM-Signature:v=1; a=rsa-sha256; c=relaxed/relaxed;
d=sjams.net; s=aliyun-eu-central-1;
t=1773912074; h=Date:From:To:Message-ID:Subject:MIME-Version:Content-Type;
bh=L+2lboukzjKa/Q9kvu+GkFMuIH29G5+61hP1o1t/l60=;
b=UfczpYjXddwC/Xa7aRoyBeeriIS5Whwsf+UHeQj8FuSKqvPlTYZRNIjxtGi3D7KdhZpsohlrJm44NAmWXySF29XPf+t/FaRyvP0RmqkdPF1YTzK2xVN+RiwehYPxc8gJBXV3JWsuKm8gl1AJqcUhVnxaT1aWlqCOWTW/Bm1LaKc=
Received: from iZxg3z5xg1gx3pZ(mailfrom:j.feedback@sjams.net fp:SMTPD_-----LY7P2F cluster:dm-ay35de-a)
by smtp.aliyun-inc.com(11.136.72.99);
Thu, 19 Mar 2026 17:21:14 +0800
X-EnvId: 25302511890
Date: Thu, 19 Mar 2026 17:21:14 +0800 (CST)
From: Thompson Emily <j.feedback@sjams.net>
Reply-To: j.feedback@sjcssp.net
To: ljerka.pavkovic@bolnica-lipik.hr
Message-ID: <5a62359f-741c-4877-b1ba-0b927d7a9416@sjams.net>
Subject: Dear Ninoslav Mimica: Call for Submission of Your Original Research
Findings - Article/Abstract
MIME-Version: 1.0
Content-Type: text/html;charset=UTF-8
Content-Transfer-Encoding: quoted-printable
X-AliDM-Settings: eyJWZXJzaW9uIjoiMS4wIiwiVW5zdWJzY3JpYmUiOnsiRmlsdGVyTGV2ZWwiOiJtYWlsZnJvbV9kb21haW4iLCJMaW5rVHlwZSI6ImRlZmF1bHQifX0=
X-Spam-Status: No, score=4.4
X-Spam-Score: 44
X-Spam-Bar: ++++
X-Ham-Report: Spam detection software, running on the system "host100322.itwesthosting.com",
has NOT identified this incoming email as spam. The original
message has been attached to this so you can view it or label
similar future email. If you have any questions, see
root\@localhost for details.
Content preview: Chemical and Biomolecular Engineering (CBE) Open-access (OA)
Journal Fast Paper Publication Dear Ninoslav Mimica, Researchers can publish
their work for a global readership across a multitude of disc [...]
Content analysis details: (4.4 points, 5.0 required)
pts rule name description
---- ---------------------- --------------------------------------------------
4.5 URIBL_DBL_SPAM Contains a spam URL listed in the Spamhaus DBL
blocklist
[URIs: sjams.net]
0.0 URIBL_BLOCKED ADMINISTRATOR NOTICE: The query to URIBL was
blocked. See
http://wiki.apache.org/spamassassin/DnsBlocklists#dnsbl-block
for more information.
[URIs: chembiomoleng.com]
0.0 RCVD_IN_VALIDITY_RPBL_BLOCKED RBL: ADMINISTRATOR NOTICE: The
query to Validity was blocked. See
https://knowledge.validity.com/hc/en-us/articles/20961730681243
for more information.
[47.245.195.73 listed in bl.score.senderscore.com]
0.0 RCVD_IN_VALIDITY_CERTIFIED_BLOCKED RBL: ADMINISTRATOR NOTICE:
The query to Validity was blocked. See
https://knowledge.validity.com/hc/en-us/articles/20961730681243
for more information.
[47.245.195.73 listed in sa-accredit.habeas.com]
-0.0 SPF_PASS SPF: sender matches SPF record
0.0 HTML_FONT_LOW_CONTRAST BODY: HTML font color similar or
identical to background
0.1 MIME_HTML_ONLY BODY: Message only has text/html MIME parts
0.0 HTML_MESSAGE BODY: HTML included in message
-0.1 DKIM_VALID Message has at least one valid DKIM or DK signature
-0.1 DKIM_VALID_EF Message has a valid DKIM or DK signature from
envelope-from domain
0.1 DKIM_SIGNED Message has a DKIM or DK signature, not necessarily
valid
-0.1 DKIM_VALID_AU Message has a valid DKIM or DK signature from
author's domain
0.0 UNPARSEABLE_RELAY Informational: message has unparseable relay
lines
X-Spam-Flag: NO
X-From-Rewrite: unmodified, forwarded message
<br/><br/><meta charset=3D'utf-8' /><html lang=3D"en"> <body><table cellspa=
cing=3D"0" cellpadding=3D"0" width=3D"100%"> <tr><td style=3D"padding:29px =
22px;background: #eeeeea;"> <table cellspacing=3D"0" cellpadding=3D=
"0" width=3D"740px"> <tr><td style=3D"width: 740px=
;background: #ffffff;"> <table cellspacing=3D"0" cellpaddin=
g=3D"0" width=3D"100%"> <tr><td style=3D"background: #f=
ffff0;"> <table cellspacing=3D"0" cellpadding=3D"0"=
width=3D"100%"> <tr><td style=3D"vertical-alig=
n:middle;width: 800px;padding: 15px 10px 15px 15px;"> =
<table cellspacing=3D"0" cellpadding=3D"0" width=3D"100%"> =
<tr><td style=3D"font-size: 20px;font-family=
: Tahoma, Arial, Helvetica, sans-serif;line-height: 35px;color: #202020;tex=
t-align:left;"><span style=3D"font-weight: bold;font-size:21px;"><font face=
=3D"Times New Roman">Chemical and Biomolecular Engineering (CBE)</font></sp=
an></td></tr> =
<tr><td style=3D"vertical-align:middle;padding=
: 15px 15px 15px 10px;width: 210px;;padding: 15px 0 0 0;"> =
<table cellspacing=3D"0" cellpadding=3D"0" width=3D"100%"> =
<tr><td style=3D"padding: 2px 0px;text-=
align: center;font-family: Tahoma, Arial, Helvetica, sans-serif;background:=
#ffdd8b;font-size: 14px;line-height:24px;color: #202020;font-size: 14px;;d=
isplay: inline-block;padding: 5px;"><font face=3D"Times New Roman">Open-acc=
ess (OA) Journal</font></td> <td style=
=3D"height: 4px;line-height: 4px;;display: inline-block;padding: 5px;">&nbs=
p;</td> <td style=3D"padding: 2px 0px;t=
ext-align: center;font-family: Tahoma, Arial, Helvetica, sans-serif;backgro=
und: #ffdd8b;font-size: 14px;line-height:24px;color: #202020;font-size: 14p=
x;;display: inline-block;padding: 5px;"><font face=3D"Times New Roman">Fast=
Paper Publication</font></td></tr></table></td></tr> =
</table> </td><td style=3D"vertical-=
align: middle;width: 80px;"> <table cellspacing=3D"0" cellp=
adding=3D"0" border=3D"0" width=3D"100%" style=3D"border:0;border-spacing:0=
;border-collapse:collapse;"><tr><td><a href=3D"http://www.chembiomoleng.com=
/lg73/intro/wsynkh" target=3D"_blank" style=3D"display: inline-block;text-d=
ecoration: none;font-size: 0;"> <table cellspacing=3D"0" cellpadding=3D=
"0" border=3D"0" width=3D"100%" style=3D"border:0;border-spacing:0;border-c=
ollapse:collapse;"><tr><td style=3D"width: 60px;height: 30px;background: #F=
E0108;text-align: right;border-top-left-radius: 50% 100%;border-top-right-r=
adius: 50% 100%;"> <table cellspacing=3D"0" cellpadding=3D"0" borde=
r=3D"0" width=3D"100%" style=3D"border:0;border-spacing:0;border-collapse:c=
ollapse;"><tr><td style=3D"height: 5px;"></td></tr></table> <table =
cellspacing=3D"0" cellpadding=3D"0" border=3D"0" style=3D"border:0;border-s=
pacing:0;border-collapse:collapse;display: inline-block;"><tr><td style=3D"=
display: inline-block;width: 50px;height: 25px;background: #F6EC02;text-ali=
gn: left;border-top-left-radius: 50% 100%;border-top-right-radius: 50% 100%=
;"> <table cellspacing=3D"0" cellpadding=3D"0" border=3D"0" wid=
th=3D"100%" style=3D"border:0;border-spacing:0;border-collapse:collapse;"><=
tr><td style=3D"height: 5px;"></td></tr></table> <table cellspa=
cing=3D"0" cellpadding=3D"0" border=3D"0" width=3D"100%" style=3D"border:0;=
border-spacing:0;border-collapse:collapse;"><tr><td style=3D"display: inlin=
e-block;width: 40px;height: 20px;background: #FE0108;text-align: right;bord=
er-top-left-radius: 50% 100%;border-top-right-radius: 50% 100%;"> =
<table cellspacing=3D"0" cellpadding=3D"0" border=3D"0" width=3D"100=
%" style=3D"border:0;border-spacing:0;border-collapse:collapse;"><tr><td st=
yle=3D"height: 5px;"></td></tr></table> <table cellspacing=
=3D"0" cellpadding=3D"0" border=3D"0" style=3D"border:0;border-spacing:0;bo=
rder-collapse:collapse;display: inline-block;"><tr><td style=3D"display: in=
line-block;width: 30px;height: 15px;background: #F6EC02;text-align: left;bo=
rder-top-left-radius: 50% 100%;border-top-right-radius: 50% 100%;"> =
<table cellspacing=3D"0" cellpadding=3D"0" border=3D"0" width=
=3D"100%" style=3D"border:0;border-spacing:0;border-collapse:collapse;"><tr=
><td style=3D"height: 5px;"></td></tr></table> <table c=
ellspacing=3D"0" cellpadding=3D"0" border=3D"0" width=3D"100%" style=3D"bor=
der:0;border-spacing:0;border-collapse:collapse;"><tr><td style=3D"display:=
inline-block;width: 20px;height: 10px;background: #00719C;border-top-left-=
radius: 50% 100%;border-top-right-radius: 50% 100%;"></td></tr></table> =
</td></tr></table> </td></tr></table> </td=
></tr></table> </td></tr></table> <table cellspacing=3D"0" cellpadd=
ing=3D"0" border=3D"0" width=3D"100%" style=3D"border:0;border-spacing:0;bo=
rder-collapse:collapse;"><tr><td style=3D"width: 60px;height: 30px;backgrou=
nd: #FE0108;text-align: left;border-bottom-left-radius: 50% 100%;border-bot=
tom-right-radius: 50% 100%;"> <table cellspacing=3D"0" cellpadding=
=3D"0" border=3D"0" width=3D"100%" style=3D"border:0;border-spacing:0;borde=
r-collapse:collapse;"><tr><td style=3D"display: inline-block;width: 50px;he=
ight: 25px;background: #F6EC02;text-align: right;border-bottom-left-radius:=
50% 100%;border-bottom-right-radius: 50% 100%;"> <table cellsp=
acing=3D"0" cellpadding=3D"0" border=3D"0" style=3D"border:0;border-spacing=
:0;border-collapse:collapse;display: inline-block;"><tr><td style=3D"displa=
y: inline-block;width: 40px;height: 20px;background: #FE0108;text-align: le=
ft;border-bottom-left-radius: 50% 100%;border-bottom-right-radius: 50% 100%=
;"> <table cellspacing=3D"0" cellpadding=3D"0" border=3D"0"=
width=3D"100%" style=3D"border:0;border-spacing:0;border-collapse:collapse=
;"><tr><td style=3D"display: inline-block;width: 30px;height: 15px;backgrou=
nd: #F6EC02;text-align: right;border-bottom-left-radius: 50% 100%;border-bo=
ttom-right-radius: 50% 100%;"> <table cellspacing=3D"0"=
cellpadding=3D"0" border=3D"0" style=3D"border:0;border-spacing:0;border-c=
ollapse:collapse;display: inline-block;"><tr><td style=3D"display: inline-b=
lock;width: 20px;height: 10px;background: #00719C;border-bottom-left-radius=
: 50% 100%;border-bottom-right-radius: 50% 100%;"></td></tr></table> =
<table cellspacing=3D"0" cellpadding=3D"0" border=3D"0" width=
=3D"100%" style=3D"border:0;border-spacing:0;border-collapse:collapse;"><tr=
><td style=3D"height: 5px;"></td></tr></table> </td></tr></=
table> <table cellspacing=3D"0" cellpadding=3D"0" border=3D=
"0" width=3D"100%" style=3D"border:0;border-spacing:0;border-collapse:colla=
pse;"><tr><td style=3D"height: 5px;"></td></tr></table> </td></=
tr></table> <table cellspacing=3D"0" cellpadding=3D"0" border=
=3D"0" width=3D"100%" style=3D"border:0;border-spacing:0;border-collapse:co=
llapse;"><tr><td style=3D"height: 5px;"></td></tr></table> </td></t=
r></table> <table cellspacing=3D"0" cellpadding=3D"0" border=3D"0" =
width=3D"100%" style=3D"border:0;border-spacing:0;border-collapse:collapse;=
"><tr><td style=3D"height: 5px;"></td></tr></table> </td></tr></table> =
</a></td></tr></table> </td></tr> </tab=
le> </td></tr> <tr><td style=3D"hei=
ght: 2px;line-height: 2px;background: #e6aa1f;"> </td></tr> =
<tr><td style=3D"background: #fffff0;"> <=
table cellspacing=3D"0" cellpadding=3D"0" width=3D"100%"> =09=09=09=09=09=
=09=09<tr><td style=3D"padding: 15px 15px 0;"> =
<table cellspacing=3D"0" cellpadding=3D"0" width=3D"100%"> =
<tr><td style=3D"background:#ffffff;padding:15px;">=
=09=09=09=09=09=09=09=09=09=09<table cellspacing=3D"0" cellpadding=3D"0" w=
idth=3D"100%"> =09=09=09=09=09=09=09=09=09=09=09<tr><td style=3D"padding-bo=
ttom: 10px;font-size: 14px;line-height:24px;font-family:Tahoma, Arial, Helv=
etica, sans-serif;text-align:left;color: #202020;">Dear Ninoslav Mimica,</t=
d></tr> =09=09=09=09=09=09=09=09=09=09=09<tr><td style=3D"padding-bottom:10=
px;font-size: 14px;line-height:24px;font-family:Tahoma, Arial, Helvetica, s=
ans-serif;text-align:left;color: #202020;">Researchers can publish their wo=
rk for a global readership across a multitude of disciplines through the <s=
pan style=3D"font-weight: bold;">300+ open-access journals</span> available=
on this platform. Over 180 journals have achieved a milestone by publishin=
g consecutively for <span style=3D"font-weight: bold;">ten years</span>.</t=
d></tr><tr><td style=3D"padding:0px;font-size: 14px;line-height:24px;font-f=
amily:Tahoma, Arial, Helvetica, sans-serif;text-align:left;color: #202020;"=
>The international journal, <span style=3D"font-style:italic;font-weight:bo=
ld;">CBE</span>, provides a channel for the exchange of powerful ideas amon=
g professionals and academics.</td></tr> =09=09=09=09=09=09=09=09=09=09</ta=
ble> =09=09=09=09=09=09=09=09=09</td></tr> =
</table> </td></tr> =
<tr><td style=3D"padding: 20px 15px 0;"> <=
table cellspacing=3D"0" cellpadding=3D"0" align=3D"center"> =
<tr><td style=3D"display: inline-block;padding: 6px 15=
px;font-size: 17px;font-weight: bold;background: #fe7129;color: #ffffff;fon=
t-family: Tahoma, Arial, Helvetica, sans-serif;line-height: 24px;text-align=
: left;">Submitting Your Original Manuscripts/Abstracts</td></tr> =
</table> </td></tr> =
<tr><td style=3D"padding: 10px 15px 0px 15px;"> =
<table cellspacing=3D"0" cellpadding=3D"0" wid=
th=3D"100%"> <tr><td style=3D"backgroun=
d: #ffffff;padding: 15px;border: 1px solid #eeeeea;"> =
<table cellspacing=3D"0" cellpadding=3D"0" width=3D"100%=
"> =
<tr><td style=3D"padding: 0 0 10px;font-size: 14px;line-hei=
ght:24px;font-family:Tahoma, Arial, Helvetica, sans-serif;text-align:left;c=
olor: #202020;">=09=09=09=09=09=09=09=09=09=09=09Since your published artic=
le <span style=3D"font-style:italic;">"Alzheimerova bolest - izazov dana=C5=
=A1njice"</span> has been widely recognized, we'd like to invite you to su=
bmit papers in your specialized/interested areas. =09=09=09=09=09=09=09=09=
=09=09</td></tr> <tr><td style=
=3D"padding: 0;font-size: 14px;line-height:24px;font-family:Tahoma, Arial, =
Helvetica, sans-serif;text-align:left;color: #202020;">Abstract/Article sub=
mission channel:<br/><a href=3D"http://www.chembiomoleng.com/se/wsynkh" tar=
get=3D"_blank" style=3D"text-decoration: none;color: #0000ff; font-weight: =
bold; white-space: nowrap;">http://www.chembiomoleng.com/se/wsynkh</a></td>=
</tr> </table> =
</td></tr> </table> =
</td></tr> <tr><td style=
=3D"padding: 20px 15px 0;"> <table cellspac=
ing=3D"0" cellpadding=3D"0" align=3D"center"> =
<tr><td style=3D"display: inline-block;padding: 6px 15px;font-size: =
17px;font-weight: bold;background: #fe7129;color: #ffffff;line-height:24px;=
font-family:Tahoma, Arial, Helvetica, sans-serif;text-align:left;">Be the M=
ember of the Editorial Board or Reviewer Team</td></tr> =
</table> </td></tr> =
<tr><td style=3D"padding: 10px 15px 25px 15px;"> =
<table cellspacing=3D"0" cellpadding=3D"0" width=3D"100=
%"> <tr><td style=3D"background: #fffff=
f;padding: 15px;border: 1px solid #eeeeea;"> =
<table cellspacing=3D"0" cellpadding=3D"0" width=3D"100%"> =09=09=
=09=09=09=09=09=09=09=09<tr><td style=3D"font-size: 14px;line-height:24px;f=
ont-family:Tahoma, Arial, Helvetica, sans-serif;text-align:left;color: #202=
020;text-align:left;"><i>CBE</i> is in pursuit of scientists who are active=
in academic activities to serve as editorial members (reviewers). Scholars=
who show interest and meet the necessary criteria are eligible to join our=
editorial board or reviewer team.</td></tr><tr><td style=3D"font-family: T=
ahoma, Arial, Helvetica, sans-serif; font-size: 14px; line-height: 24px; te=
xt-align:left;padding-top:10px;">You can find the conditions and steps for =
being the editorial member of reviewer via:<br><a href=3D"http://www.chembi=
omoleng.com/jy/wsynkh" target=3D"_blank" style=3D"text-decoration: none;col=
or: #0000ff; font-weight: bold; white-space: nowrap;">http://www.chembiomol=
eng.com/jy/wsynkh</a></td></tr> </=
table> </td></tr> =
</table> </td></tr> =
<tr><td style=3D"padding: 0px 15px=
20px;"> <table cellspacing=3D"0" cellpaddi=
ng=3D"0" width=3D"100%"> <tr><td style=
=3D"background: #ffffff;"> <table c=
ellspacing=3D"0" cellpadding=3D"0" width=3D"100%"> =
<tr><td style=3D"padding: 10px 15px 10px;font-size: 14p=
x;line-height:24px;font-family:Tahoma, Arial, Helvetica, sans-serif;text-al=
ign:left;color: #202020;">From the condition of the Editorial/Reviewer Team=
, we can see the quality of the Journal. Several Editorial Board Members an=
d Reviewers of <i>CBE</i> are presented here.</td></tr> =
<tr><td style=3D"background: #ffffff;border-top: 1=
px dashed #e6aa1f;"> <table=
cellspacing=3D"0" cellpadding=3D"0" width=3D"100%"> =
<tr><td style=3D"padding: 10px 15px;font-size=
: 14px;line-height:24px;font-family:Tahoma, Arial, Helvetica, sans-serif;te=
xt-align:left;color: #202020;"><span style=3D"padding-right: 12px;color: #f=
e7129;color:#202020;">Dr. Udit Gupta</span>Department of Chemicals, Siemens=
Digital Industries Software, Parsippany, United States</td></tr> =
<tr><td style=3D"padding: 0 15px=
10px;font-size: 14px;line-height:24px;font-family:Tahoma, Arial, Helvetica=
, sans-serif;text-align:left;color: #202020;"><span style=3D"padding-right:=
12px;color: #fe7129;color:#202020;">Assist. Prof. Lidiya Petrova</span>Dep=
artment of Anatomy, Histology, Cytology and Biology, Medical University - P=
leven, Pleven, Bulgaria</td></tr> =
<tr><td style=3D"padding: 0 15px 10px;font-size: 14px;line-heigh=
t:24px;font-family:Tahoma, Arial, Helvetica, sans-serif;text-align:left;col=
or: #202020;"><span style=3D"padding-right: 12px;color: #fe7129;color:#2020=
20;">Dr. Gustavo Alejandro Hernandez Fuentes</span>Department of Molecular =
Sciences, University of Colima, Colima, Mexico</td></tr> =
<tr><td style=3D"padding: 0 15px 10px;fon=
t-size: 14px;line-height:24px;font-family:Tahoma, Arial, Helvetica, sans-se=
rif;text-align:left;color: #202020;"><span style=3D"padding-right: 12px;col=
or: #fe7129;color:#202020;">Assist. Prof. Jitendra Sunte</span>Department o=
f Mechanical Engineering, Lingaraj Appa Engineering College Bidar, Bidar, I=
ndia</td></tr> =09=09=09=09=09=09=09=09=09=09=09=09=09<tr><td style=3D"padd=
ing: 0 15px 10px;font-size: 14px;line-height:24px;font-family:Tahoma, Arial=
, Helvetica, sans-serif;text-align:left;color: #202020;"><span style=3D"pad=
ding-right: 12px;color: #fe7129;color:#202020;">Xinghua Li</span>Pharmacy D=
epartment, Changzhi People's Hospital Affiliated to Changzhi Medical Colleg=
e, Changzhi, China</td></tr> =
</table> </td></tr> =
</table> =
</td></tr> </table> =
</td></tr> <tr><td style=3D"padding: 0 15=
px 15px;"> <table cellspacing=3D"0" cellpad=
ding=3D"0" width=3D"100%"> <tr><td styl=
e=3D"padding: 15px;background: #ffffff;font-size: 14px;line-height:24px;fon=
t-family:Tahoma, Arial, Helvetica, sans-serif;text-align:left;color: #20202=
0;"><table cellspacing=3D"0" cellpadding=3D"0" border=3D"0" width=3D"100%">=
<tr><td style=3D"padding:0px;font-family: Tahoma, Arial, Helvetica, sans-se=
rif; font-size: 14px; line-height: 24px; text-align: justify;color:#272727;=
">The following part shows your article's title and abstract:</td></tr><tr>=
<td style=3D"padding:0px;font-family: Tahoma, Arial, Helvetica, sans-serif;=
font-size: 14px; line-height: 24px; text-align: justify;color:#272727;"><s=
pan style=3D"font-weight:bold;">Title of the research paper mentioned above=
:</span> Alzheimerova bolest - izazov dana=C5=A1njice</td></tr><tr><td styl=
e=3D"padding:0px;font-family: Tahoma, Arial, Helvetica, sans-serif; font-si=
ze: 14px; line-height: 24px; text-align: justify;color:#272727;"><span styl=
e=3D"font-weight:bold;">Abstract of the research paper mentioned above:</sp=
an> Alzheimerova bolest (AB) danas, kao jedna od tipi=C4=8Dnih i =C4=8Desti=
h bolesti III. =C5=BEivotne dobi, a u kontekstu kada udio starijih osoba u =
populaciji konstantno raste, dobiva sve vi=C5=A1e na zna=C4=8Denju. Kao i u=
drugim slu=C4=8Dajevima, kada je podignuta dru=C5=A1tvena svjesnost o bole=
sti, o potrebi =C5=A1to ranijeg dijagnosticiranja i lije=C4=8Denja, neminov=
no dolazimo do situacije kada oboljeli, a onda i njihove obitelji, sve dulj=
e vremena =C5=BEive s dijagnozom AB. Tu, svakako optere=C4=87uju=C4=87u poz=
iciju moramo amortizirati putem sustavnog i svekolikog post-dijagnosti=C4=
=8Dkog suporta, koji treba biti individualno skrojen, uva=C5=BEavaju=C4=87i=
sve specifi=C4=8Dne afinitete pojedinca s jedne strane, te preostale osobn=
e mogu=C4=87nosti (koje zavise od stupnja te=C5=BEine bolesti) s druge stra=
ne. Multidisciplinarni pristup podr=C5=A1ke usmjeren prema osobi i njegovat=
elju klju=C4=8D je kvalitetne skrbi za osobe s neurokognitivnim poreme=C4=
=87ajima. Pred dana=C5=A1njim znanstvenicima stoji (te=C5=BEak) zadatak det=
ekcije AB u fazi prije pojave klini=C4=8Dkih simptoma, i to putem pouzdane,=
neinvazivne, lako primjenljive i jeftine metode. Nakon takvog budu=C4=87eg=
testiranja osoba s pove=C4=87anim rizikom ili =C4=8Dak mo=C5=BEda i skrini=
nga populacije, biti =C4=87e potrebno u pozitivnih osoba primijeniti inovat=
ivnu terapiju koja =C4=87e imati mogu=C4=87nost modificiranja prirodnog tij=
eka bolesti, na na=C4=8Din da ga odgodi (za makar 5 godina), =C5=A1to bi om=
ogu=C4=87ilo ve=C4=87ini oboljelih da tijekom =C5=BEivota ne razviju te=C5=
=BEu, onesposobljavaju=C4=87u klini=C4=8Dku sliku demencije. Naime, u dana=
=C5=A1nje doba, kada mnoge starije osobe =C5=BEive same, vrlo je va=C5=BEno=
stvoriti uvjete koji bi im omogu=C4=87ili =C5=A1to dulje funkcioniranje be=
z ili samo s manjom tu=C4=91om pomo=C4=87i. U tome =C4=87e sve vi=C5=A1e i =
vi=C5=A1e imati udjela i napredna asistivna tehnologija koja =C4=87e putem =
raznih aplikacija, tehnolo=C5=A1kih pomagala, pa i robota, pomagati stariji=
m osobama. Trebati =C4=87e jo=C5=A1 neko (kra=C4=87e) vrijeme dok se ne pro=
na=C4=91u u=C4=8Dinkovitiji lijekovi od postoje=C4=87ih, na tome se intenzi=
vno radi, testiraju se razli=C4=8Dite supstance i pristupi, na pr. lijekovi=
koji djeluju na tau-protein, imunoterapija, infuzije, vakcine. Upravo zbog=
toga =C5=A1to se u slu=C4=8Daju AB i drugih demencija radi o javnozdravstv=
enom prioritetu potrebno je, radi najbolje skrbi za osobe s demencijom, ima=
ti nacionalnu strategiju koja =C4=87e definirati klju=C4=8Dne ciljeve, stan=
dardne postupke i trenutne prioritete. Takav pristup pomo=C4=87i =C4=87e ob=
oljelima, njihovim bli=C5=BEnjima a onda i cijelom dru=C5=A1tvu.</td></tr><=
/table></td></tr> </table> =
</td></tr> </table> =
</td></tr> </table> </td></tr> </table=
></td></tr><table style=3D"width:740px;"><tr><td style=3D"font-size: 14px;t=
ext-align:center;padding: 20px 0;line-height:18px;font-family:Tahoma, Arial=
, Helvetica, sans-serif;color: #202020;">Would like to be taken off the mai=
ling list? <a href=3D"http://www.chembiomoleng.com/us/wsynkh" border=3D"0" =
target=3D"_blank" style=3D"display:inline-block;background:#ffc61d;padding:=
2px 6px;border-radius:6px;text-decoration:none;color:#191919;white-space:no=
wrap;font-size:15px;line-height:18px;">Unsubscribe</a></td></tr></table> </=
table></body></html>=20